Determining if Positive Predictive Value using Laboratory Risk Indicator for Necrotising Fasciitis is Applicable in

A Syed1, T Alvin1, A Fazrina1

  • 1Department of Orthopaedics, Hospital Tuanku Ja'afar Seremban, Seremban, Malaysia.

Insights

The Laboratory Risk Indicator for Necrotising Fasciitis (LRINEC) score is not a reliable tool for differentiating necrotising fasciitis from other soft tissue infections in Malaysia. This study found low sensitivity and predictive values, indicating its unsuitability for sole diagnostic use.

Area of Science:

  • Infectious Diseases
  • Surgical Pathology
  • Diagnostic Accuracy

Background:

  • Necrotising fasciitis (NF) is a severe, rapidly progressing soft tissue infection.
  • The Laboratory Risk Indicator for Necrotising Fasciitis (LRINEC) score was developed to aid in distinguishing NF from other soft tissue infections (STI).
  • The applicability of the LRINEC score in diverse clinical settings, such as Malaysia, requires validation.

Purpose of the Study:

  • To evaluate the diagnostic accuracy of the LRINEC score in a Malaysian population.
  • To determine the sensitivity, specificity, and predictive values of the LRINEC score for identifying necrotising fasciitis.

Main Methods:

  • A cross-sectional study was conducted on patients admitted with suspected or confirmed necrotising fasciitis.
  • The LRINEC score was calculated for each patient.
  • Diagnostic performance metrics were assessed for LRINEC score thresholds of ≥ 6 and ≥ 8.

Main Results:

  • Of 44 patients, 27 (61.4%) had confirmed NF.
  • A LRINEC score ≥ 6 showed 59.3% sensitivity and 47.1% specificity (PPV 64.0%, NPV 42.1%).
  • A LRINEC score ≥ 8 showed 48.1% sensitivity and 58.8% specificity (PPV 65%, NPV 41.7%).

Conclusions:

  • The LRINEC score demonstrated low sensitivity and low positive predictive values in this Malaysian cohort.
  • These findings suggest the LRINEC score is not suitable as a standalone diagnostic tool for necrotising fasciitis.
  • Further research may be needed to identify more effective diagnostic markers for NF.